Table of Contents
Volume 1 | Issue 1
Publication Date: August 1999- Abstract
- No Access
- Pay-Per View
- Full Text
- Add to Cart
Editorial | ||
8 |
Clinical Lung Cancer Creation of an important “byte” through formation of an “access” Chandra P. Belani |
|
Meeting Highlight | ||
11-17 |
1999, 35th Annual ASCO Meeting Angelia D. Gibson |
|
Researches in Brief | ||
23-24 |
Summary of Phase III Trials: Paclitaxel Plus Carboplatin Versus Vinorelbine Plus Cisplatin CIG Media Group |
|
25-26 |
Docetaxel Versus Best Supportive Care as 2nd Line Treatment CIG Media Group |
|
27-28 |
Two Doses of Docetaxel Versus Vinorelbine or Ifosfamide as 2nd Line Therapy CIG Media Group |
|
29-30 |
Four Platinum Based Doublets in Patients with Advanced Non–Small-Cell Lung Cancer: Preliminary Results of PS2 Patients CIG Media Group |
|
Comprehensive Review | ||
34-41 |
Treatment Strategies for Metastatic Non–Small-Cell Lung Cancer David H. Johnson |
|
Imaging in Lung Cancer | ||
42-48 |
Positron Emission Tomography Imaging in Lung Cancer Edward F. Patz, Jr., Jeremy J. Erasmus |
|
Commentary | ||
49 |
Commentary on “PET Imaging in Lung Cancer” Philip A. Templeton |
|
Translational Medicine | ||
50-55 |
Cancer Treatment Involving Oncolytic Viruses John J. Nemunaitis |
|
Viruses in Cancer Treatment | ||
56 |
Commentary on “Viral Oncolytic Treatment of Cancer” Stephen G. Swisher |
|
Original Contribution | ||
59-67 |
Prognostic Markers in Resected Stage I and II Non–Small-Cell Lung Cancer: An Analysis of 260 Patients with 5 Year Follow-Up Syed A. Mehdi, Arthur H. Tatum, Nancy B. Newman, Gary P. Gamble, Joan E. Etzell, Noel Weidner, Jeffrey A. Kern, Steven M. Sorscher, Leslie J. Kohman, Stephen L Graziano |
|
Commentary | ||
68-69 |
Commentary on “Prognostic Markers in Resected Stage I and II Non–Small-Cell Lung Cancer Patients” David H. Harpole Jr |
|
Current Trials | ||
70-72 |
Carcinoembryonic Antigen Peptide-Pulsed Dendritic Cells in Patients with Metastatic Cancer H. Kim Lyerly, Michael A. Morse |
|
Brief Comunication | ||
73-75 |
Carboplatin and Gemcitabine Chemotherapy for Malignant Pleural Mesothelioma: A Phase II Study of the GSTPV Savina M.L. Aversa, Adolfo G. Favaretto |
|